Stocks
ResMed (RMD) FCF conversion US GAAP (year values) |
|||||||||
| FY2023 | FY2024 | FY2025 | FY2026 | FY2026 | LTM ? | 5 years average | |||
| FCF conversion, % | 41.2% | 83.9% | 86.8% | 76.9% | 76.9% | 83.5% | |||
| Changes by years, y/y, % | +25pp | +43pp | +3pp | -10pp | 0pp | +61% | |||
ResMed. FCF conversion, %
ResMed. FCF conversion, changes, pp
ResMed (RMD) FCF conversion US GAAP (quarter values) |
||||||||
| FY2026Q2 | FY2026Q3 | FY2026Q3 | FY2026Q4 | FY2026Q4 | LTM ? | |||
| FCF conversion, % | 53.9% | 89.2% | 89.2% | 334.6% | 334.6% | 83.5% | ||
| Changes by years, y/y, % | -7pp | -29pp | -29pp | +239pp | +239pp | |||
| Changes by quarters, q/q, % | -28pp | +35pp | 0pp | +245pp | +0pp | |||
